🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

ESSKA/ESMA ACL Injury Prevention Program in Czech Sport

RecruitingNAAges 17 Years - 20 YearsAllMasaryk University
NCT07019727 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study aims to address the rising incidence of ACL injuries, particularly among adolescents, by developing and implementing a comprehensive prevention program based on the evidence-based "ACL Prevention for ALL" framework recommended by ESSKA-ESMA. The project focuses on muscle strengthening, flexibility, coordination, proper movement techniques, and a multidisciplinary approach involving coaches, physiotherapists, and physicians. Through targeted exercise modules, education, and dynamic evaluation-including 2D motion analysis-the study seeks to reduce ACL injuries, enhance movement safety, and enable individualized training plans by identifying and correcting muscle and biomechanical imbalances.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age group: Participants aged 17-20 years Sports activity: Individuals actively engaged in sports with a high risk of ACL injury Health status: Participants with no or minimal previous knee joint injuries that do not limit their current physical activity Willingness to participate: Agreement to take part in the prevention program, including regular training and assessments Informed consent: Signed informed consent for participation in the program and testing procedures; for minors, consent must be signed by legal guardians Exclusion Criteria: Current injury: Individuals with a current knee joint injury requiring treatment or surgery Chronic conditions: Participants with chronic diseases or conditions that may affect the outcome of injury prevention (e.g., congenital abnormalities, neuromuscular disorders, or cardiovascular diseases) Insufficient consent: Individuals who are unable or unwilling to provide written informed consent Irregular participation: Individuals who do not comply with regular participation in the training program or assessments
💊

What it tests

  • ESSKA/ESMA 'ACL Prevention for All' methodology
📍

Where

1 site
Faculty of Medicine, Masaryk University
Brno, Czechia
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy